Skip to main content
RXRX logo

RXRX · Recursion Pharmaceuticals, Inc. · Short Interest

Track RXRX — free
$3.70 +0.12 (+3.35%) At close · Oct 23
Market Cap
$1.98B
Shares
535.34M
Volume · Oct 23 19.08M Avg daily vol (3M) 21.75M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

RXRX Latest Reported Short Interest

FINRA reported 157,938,412 RXRX shares sold short as of the September 30, 2026 settlement date, a decrease of 20,786,021 shares. Days to cover was 6.13 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

RXRX Short Interest Forecast

Equibles' model estimates 156,689,815 shares sold short for the October 15, 2026 settlement, -0.8% versus the latest reported position, with a likely range of 140,071,104 to 172,955,820 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 Low confidence 48% chance it rises
156,689,815 -0.8% vs reported
Likely range 140,071,104 to 172,955,820 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
74/100
Short interest 29.5% of shares — P100 Days to cover 6.1 — P78 Price vs VWAP -0.7% — P67 Short-volume trend -1.5% — P46 Short interest change -11.6% — P22 Worst FTD 0.51% of shares — P94

Positioning score 74.1 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-25 08:29 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 157,938,412 178,724,433 -20,786,021 6.13
2026-09-15 178,724,433 179,145,796 -421,363 12.56
2026-08-31 179,145,796 177,923,359 +1,222,437 10.60
2026-08-14 177,923,359 180,771,459 -2,848,100 13.37
2026-07-31 180,771,459 180,760,541 +10,918 9.31
2026-07-15 180,760,541 172,302,180 +8,458,361 6.72
2026-06-30 172,302,180 184,017,785 -11,715,605 8.39
2026-06-15 184,017,785 164,340,230 +19,677,555 8.36
2026-05-29 164,340,230 184,440,829 -20,100,599 8.02
2026-05-15 184,440,829 171,321,811 +13,119,018 13.28
2026-04-30 171,321,811 174,397,876 -3,076,065 14.78
2026-04-15 174,397,876 173,926,845 +471,031 17.12
2026-03-31 173,926,845 174,136,749 -209,904 12.29
2026-03-13 174,136,749 168,516,142 +5,620,607 12.67
2026-02-27 168,516,142 173,170,498 -4,654,356 8.86
2026-02-13 173,170,498 165,548,707 +7,621,791 7.63
2026-01-30 165,548,707 163,381,460 +2,167,247 7.95
2026-01-15 163,381,460 165,731,774 -2,350,314 8.15
2025-12-31 165,731,774 153,738,758 +11,993,016 6.14
2025-12-15 153,738,758 151,875,532 +1,863,226 8.22
2025-11-28 151,875,532 145,661,814 +6,213,718 6.48
2025-11-14 145,661,814 128,586,047 +17,075,767 3.89
2025-10-31 128,586,047 126,348,417 +2,237,630 1.99

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 51 filings 51 filers Visit website Investor relations